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Smoking, depression, and hospital costs of respiratory cancers:
Examining race and sex variation
Baqar A. Husaini1, Robert S. Levine2, Phillip Lammers3, Pam Hull4, Meggan Novotny5, Majaz Moonis6

Abstract
Objective: To investigate the effect of smoking and depression on hospital costs for lung
cancer (LC).
Methods: We extracted data on depression, smoking history, demographics, and hospital
charges for patients with respiratory cancers (ICD-9 codes 161–163, 165) from the 2008 Tennessee
Hospital Discharge Data System. The sample (n=6665) was mostly white (86%) and male (57%).
Age-adjusted rates were developed in accordance with Centers for Disease Control and Prevention
methods, and hospital costs were compared for patients with LC with versus without depression
and a smoking history.
Results: Three findings (P<0.001) emerged: (1) the LC rate was higher among blacks than
among whites, and higher among men than among women; (2) while 66% of LC patients smoked
(more men than women without racial variation), 24% had depression (more females and whites
were depressed); (3) the LC hospital cost was 54% higher than the non-LC hospital cost, and this
cost doubled for patients with LC with depression and smoking versus those without such characteristics.
Conclusion: While LC is more prevalent among blacks and men, depression is higher among
female and white patients. Since depression with higher costs existed among LC patients, our findings point to (1) the possibility of cost savings by diagnosing and treating depression among LC
patients, and (2) implementation of proven smoking cessation programs to reduce LC morbidity
and hospital costs.
Keywords: Smoking; depression; lung cancer; race; sex

Background

cancer globally, and is highly correlated

Respiratory cancers include cancers of the lar-

with smoking and old age [1, 2]. The aver-

ynx, pleura, bronchus, and lungs. Malignant

age age of US lung cancer patients is around

neoplasm of the trachea, bronchus, and lungs,

70 years, and the US lifetime risk of develop-

commonly known as lung cancer, constitutes a

ing lung cancer at age 70 years or older is 1

large proportion of respiratory cancers in the

in 16 (6.4%) for men and 1 in 21 (4.8%) for

United States, and according to the Centers

women [3]. Lung cancer is a leading cause

for Disease Control and Prevention (CDC), it

among all causes of US death for individuals

accounts for 137,000 American deaths annu-

aged 60 years or older [3]. Smoking is preva-

ally. Lung cancer is also the most common

lent in 80%–90% of lung cancer patients
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[4], who occupy 28% of all hospital beds annually [5]. The

difficulties performing work and activities of daily living [13].

age-adjusted incidence rate of lung cancer (per 100,000) in

There is also some evidence that indicates that smoking starts

the United States is highest in states that produce tobacco or

in some cases at early ages, while in others it may develop as a

have higher rates of smoking. For example, Utah, a predomi-

coping response to stressors [14–17]. Available data, however,

nantly Mormon non-tobacco-producing state where observant

suggest that smoking and depression are highly correlated

Mormons are not allowed to smoke, has the lowest rates (34.7

in that depressed individuals have a higher rate of smoking

for males and 23.7 for females), compared with a high rate

[18–21]. While the causal direction of the smoking–depres-

(120.4 for males vs. 80.7 for females) in Kentucky, a major

sion relationship remains unclear, evidence clearly indicates

tobacco-producing state [3].

that depressed individuals are more likely to smoke than nondepressed individuals, and that depressed individuals are less

Smoking, sex, and lung cancer

likely to be successful in their attempts to quit smoking than

According to the CDC [6], while the smoking rate declined from

non-depressed individuals [18–21]. Further, a recent brief from

20.9% in 2005 to nearly 17% in 2014, the proportion of male

the CDC noted that more than 60% of depressed individuals

smokers remained higher than the proportion of female smokers

had smoked, and that their smoking rate increased with the

(18.8% and 14.8% respectively). With the decline in smoking, a

severity of depression. Moreover, age- and sex-specific data

similar decline in the incidence of lung cancer (per 100,000) has

have consistently shown that more depressed adults not only

also occurred, from a 2008 rate of 89.0 for males and 55.2 for

smoked more often but also that they were more likely to be

females [7] to 76.7 for males and 54.1 for females in 2012 [3].

heavy smokers compared with non-depressed adults. Finally,

This decline, which has been observed in most states, has been

depressed adults have been found to be less likely to quit

greater for males than for females [3]. However, because of, in

smoking than non-depressed individuals [22].

part, a higher prevalence of smoking among males [8], lung
cancer rates have remained higher for males than for females.

Cardiovascular disease risk factors and lung
cancer

Smoking, race, and lung cancer

While cancer, diabetes mellitus, and other CVD risk factors

In the past, a higher prevalence of smoking has been reported

have collectively contributed to 65% of all deaths in recent

among blacks [9], with different risk factors for lung cancer

years [23], the relationships between specific CVD risk fac-

among blacks who smoked heavily [10]. However, smoking

tors and lung cancer has remained mixed. For instance, while

prevalence now appears to be similar between blacks and

in six studies lung cancer was unrelated to diabetes [24–29],

whites (17.5% vs. 18.2% respectively) [6]. Nonetheless, the

three studies found significant evidence for such a relationship

incidence of lung cancer in black males was 21% higher in

[30–32]. Other studies have pointed to a higher prevalence of

2012 than that in white males (85.6 vs. 70.9 respectively) [11].

liver, pancreas, endometrium, colon/rectum, breast, and blad-

The higher rate of lung cancer among blacks appears to be

der cancers among obese and diabetic patients [33–44]. While

consistent with their higher rates of smoking in the past [9].

cholesterol level was unrelated to lung cancer in two studies

The rate for lung cancer among black females was consist-

[45, 46], hypertension was associated with cancer among male

ently lower than that among white females from 2008 (51.1 vs.

smokers [47]. Lung cancer was also related to angina, myocar-

57.0 respectively) [7] to 2012 (44.3 vs. 69.3 respectively) [11].

dial infarction, and stroke that may develop within 14 months

Additionally, the 5-year survival rate after a cancer diagnosis

after lung cancer diagnosis [48]. These coronary heart dis-

is lower among blacks than among whites [12].

ease (CHD) factors (angina, myocardial infarction, or stroke)
were characteristic of patients whose cancer had metastasized

Smoking and depression

[49]. Lung cancer also existed among smokers who either self-

Recent evidence suggests that 7.6% of the US population has

reported that diagnosis or in whom angina, myocardial infarc-

depression, and 43% of seriously depressed individuals have

tion, or stroke had been reported [50–52]. Further, lung cancer
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patients have been reported to develop atrial fibrillation as a

The sample patients had a mean age of 67 years (range

result of cancer surgery or other cancer therapies (12%–20%

20–99 years) and it included 57% men and 86% whites. The

of patients develop atrial fibrillation in the postsurgery period)

sample patients had on average nearly three comorbidities,

[53–56]. There is a high prevalence of atrial fibrillation not

including conditions such as hypertension, diabetes mel-

only among lung cancer patients but also among patients with

litus, and COPD. There was age variation by race, whereby

colorectal cancer [57]. An inflammatory state among these

black patients tended to be younger than white patients (mean

patients is believed to promote atrial fibrillation [58–61].

age+standard deviation 64.4+11.21 years vs. 67.8+11.21 years

The occurrence of chronic kidney disease and other comor-

respectively).

bidities increases with age [62]. Overall, chronic kidney disease (as measured by estimated glomerular filtration rate)

Data characteristics

is unrelated to lung, prostate, breast, and colorectal cancers.

HDDS files provide patients’ basic demographics such as age,

However, reduced estimated glomerular filtration rate or end-

race, sex, county and zip code of residence, ICD-9 diagnostic

stage renal disease, in particular, is associated with lung can-

codes (both primary and secondary diagnoses) for which an

cer [63, 64]. Finally, chronic obstructive pulmonary disease

inpatient was treated, and the number of admissions, number

(COPD), which is an accelerated decline in lung functioning, is

of days in hospital, and charges (dollars) for each discharge.

highly related to lung cancer [65, 66]. Moreover, COPD is also

Only the attending physicians gave diagnoses, which included

a risk factor for CVD events such as heart failure [62, 66]. In

diagnoses of any smoking history (covering past/present

sum, lung cancer is reported to be related to a number of CVD

smoking, as well as smoking abuse), depression, and anxiety.

risk factors, including hypertension, diabetes, angina, myocar-

Since there is a high overlap in symptoms of depression and

dial infarction, stroke, atrial fibrillation, COPD, and smoking.

anxiety (ranging from 48% to 91%) [68, 69], we combined the

While the consequences of smoking relative to CVD and
lung cancer are well known [1, 2], and the relationship between

diagnoses of depression and anxiety as a single variable for
our analyses [70].

smoking and depression has been carefully examined [14–22],

The secondary diagnoses (ICD-9 codes) for conditions

what remains unknown is the effect of smoking and depres-

such as hypertension and diabetes mellitus were used as CVD

sion on hospital costs for lung cancer patients. In our analyses

risk factors for lung cancer. The HDDS files do not provide

of hospital-discharged patients, we focus on two issues by race

clinical data on various tests performed or medications admin-

and sex: (i) the prevalence of smoking, depression, and lung

istered. Since the Tennessee population is largely composed of

cancer along with CVD risk factors that characterize lung can-

whites (77%) and African Americans (16%), we focused on

cer patients, and (2) variations in the effect of smoking and

comparing lung cancer rates, risk factors, and estimated costs

depression on hospital costs for lung cancer.

across African Americans (blacks) and white groups.
We used an index of comorbidity that was simply a sum

Methods
Sample characteristics

of all secondary diagnoses identified by ICD-9 codes for each

We examined 2008 Tennessee Hospital Discharge Data

reimbursed dollars for services, we used the submitted charges

System (HDDS) files for patients (aged 20 years or older)

as an estimated cost of lung cancer for the year 2008. We com-

discharged with any diagnosis of respiratory cancer (ICD-9

puted total hospital charges/costs for the year, which included

codes 161, 163, 165), including cancer of the bronchus/lungs

lung cancer cost as well as the cost for the same patient when

(ICD9-9 code 162). There were 6665 patients with respiratory

he/she was readmitted with diagnoses other than lung cancer.

cancers, and 95% of them (6332) had lung cancer, a figure that

These costs included room charges per night, along with the

is closely aligned with the percentage of lung cancer among

cost of medications, supplies, and tests and procedures done

respiratory cancer deaths in Tennessee among individuals

on the patient. Physicians’ charges were not included in the

aged 20 years or older for 2008 (98% of 4423 deaths) [67].

hospital costs.
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Statistical analysis

P<0.001). The prevalence is higher among men overall and

Age-adjusted lung cancer prevalence (per 100,000 population,

among blacks of both sexes.

2010 US Census) were computed for race and sex groups in
accordance with CDC methods [71]. Differences in the preva-

Cardiovascular disease risk factors in lung cancer

lence of lung cancer risk factors by sex and race were evalu-

We examined risk factors in two ways: (1) by means of a

ated with the Pearson χ2 test and the Fisher’s exact test. To

simple comparison of the percentage of risk factors for each

examine the likelihood of lung cancer association with each

lung cancer subgroup (Table 1), and (2) by use of multivariate

CVD risk factor, logistic regression models (odds ratio [OR]

logistic regression models that predicted lung cancer (Table 2)

and 95% confidence interval [CI]) were used on the total

from various risk factors. Table 1 shows that compared with

sample first and then for each subgroup separately. Finally,

patients without lung cancer, patients with lung cancer had a

ANOVA and t tests were used to examine group differences

higher prevalence of some CVD factors, including hyperten-

for cost variables.

sion (64% vs. 53%, P<0.001), CHD (34% vs. 25%, P<0.001),
atrial fibrillation (29% vs. 18%, P<0.001), COPD (62% vs.

Results
Prevalence of smoking, depression, and lung cancer
Smoking history: The smoking history of the patients was

18%, P<0.001), smoking history (66% vs. 28%, P<0.001), obe-

composed of “ever smoked” and “tobacco abuse.” We com-

the subgroup of lung cancer patients. For example, depressed

bined these two variables to create a variable of smoking his-

patients compared with non-depressed lung cancer patients had

tory that included both past smokers and abusers. Our analysis

a higher prevalence of hypertension (70% vs. 61%, P<0.001),

shows that more men than women had a smoking history (68%

diabetes (27% vs. 24%, P<0.01), CHD (37% vs. 33%, P<0.01),

vs. 64%, P<0.01; Table 1), with no racial differences in smok-

atrial fibrillation (33% vs. 28%, P<.01), smoking history (74%

ing (67% among blacks vs. 66% among whites).

vs. 64%, P<0.001), and COPD (72% vs. 59%, P<0.001). The

sity (1.9% vs. 0.4%, P<0.04), and depression (24% vs. 20%,
P<0.01). There were some variations in the CVD predictors by

higher prevalence of both COPD and depression in relation to

Depression: One-fourth of patients (24.0%) had depres-

smoking confirms findings reported by others [22].

sion; the rate of depression was higher among white patients

Our analysis of those who had both a smoking history

than among black patients (26% vs. 14%, P<0.001) and higher

and depression revealed that they significantly (P<0.001)

among women than among men (32% vs. 18%, P<0.001;).

had a higher prevalence of hypertension, diabetes, CHD,

Further, a significant (P<0.001) proportion of white women

high cholesterol level, atrial fibrillation, and COPD com-

(34%) had depression compared with other subgroups, includ-

pared with patients without a smoking history and depres-

ing one-tenth of black men who were depressed. From our data

sion (Table 1). However, there were some variations by

it was not clear whether these patients had depression before

race, such as black lung cancer patients compared with their

their hospital admission or whether their depression developed

white peers had a higher prevalence of hypertension (73%

after hospital admission.

vs. 62%, P<0.001), diabetes (30% vs. 24%, P<0.01), and
chronic kidney disease (13% vs. 10%, P<0.001). The white

Age-adjusted prevalence: The age-adjusted lung can-

lung cancer patients in comparison had a higher prevalence

cer prevalence was 142.9 per 100,000 for the total sample

of CHD (35% vs. 25%, P<0.001), atrial fibrillation (29%

(Table 1), with blacks having a higher rate than whites (146.6

vs. 25%, P<0.01), COPD (63% vs. 52%, P<0.001), and

vs. 131.6, P<0.001). Prevalence was also higher among men

depression (26% vs. 14%, P<0.001). The higher prevalence

than among women (174.9 vs. 119.9, P<0.001), and it was

of CHD, atrial fibrillation, and COPD among whites was

higher, in particular, among black men than among white men

largely contributed by white men (Table 1). There were no

(201.2 vs. 171.3, P<0.001). Similarly, higher rates existed for

racial differences in smoking history, obesity, or myocardial

black women compared with white women (111.1 vs. 103.4,

infarction, or stroke (Table 1).
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In our multivariate logistic regression analyses (Table 2),

nonsmokers ($80,848 vs. $56,931, P<0.001), and 40% higher

the association of many of these CVD risk factors with lung

among depressed patients than among non-depressed patients

cancer was attenuated except for four factors – namely, atrial

($97,265 vs. $65,075, P<0.001). Clearly, smoking and depres-

fibrillation (OR 1.40, 95% CI 1.38–1.48), COPD (OR 5.25,

sion individually contribute to higher hospitalization costs of

95% CI 4.96–5.55), smoking (OR 3.03, 95% CI 2.86–3.20),

lung cancer patients.

and obesity (OR 2.87, 95% CI 2.37–3.47). These four factors were consistently associated with lung cancer across all

Combined effect of smoking and depression: Finally,

lung cancer subgroups (Table 2). Diabetes, CHD, myocardial

18% of all lung cancer patients (Table 3) were both smokers

infarction, or stroke did not emerge as a significant contribu-

and depressed. The costs for these patients doubled compared

tor to lung cancer as was previously reported by others [49,

with those for lung cancer patients who were not smokers or

50]. Finally, some racial and sex variations existed in that

depressed ($104,434 vs. $52,216, P<0.0001; Table 3). The

black lung cancer patients were more likely to have hyper-

effect of these two factors combined (smoking history and

tension than whites (OR 1.37, 95% CI 1.16–1.6). This rela-

depression) was more pronounced for blacks than for whites

tionship appears to emerge largely because of hypertension

($141,480 vs. $101,620, P<0.001; Table 4), and also greater for

among black women (OR 2.00, 95% CI 1.53–2.62). Among

male patients than for female patients ($113,480 vs. $97,324,

whites, cholesterol was related to lung cancer (OR 1.16, 95%

P<0.001; Table 4). Further, these effects were significantly

CI 1.06–1.27), which largely was due to white women with

greater for black men and black women compared with their

high cholesterol levels (OR 1.19, 95% CI 104–1.36). Neither

white peers (Table 5).

smokers nor depressed patients had any other additional risk
factor associated with lung cancer besides atrial fibrillation,

Discussion

COPD, obesity, and smoking (Table 2).

It may be noted that our sample of patients represented serious
cases that required hospitalization. These patients included

Effect of depression and smoking on hospital costs
Overall hospitalization cost: Hospitalization costs in a

both new cases (diagnosed in 2008) and old cases; that is,

year are largely affected by three factors: the patients’ number

made by the attending physicians. The diagnoses appeared in

of comorbidities, number of hospital admissions, and length

the records only when the patient was treated for those condi-

of stay (days) in the hospital. Table 3 shows that the average

tions. With this background, our analyses revealed that while

total hospital cost for lung cancer patients was 54% higher than

there were no racial differences in smoking, significant differ-

that for patients without lung cancer ($71,850 vs. $41,264,

ences did emerge with regard to depression (24%) that appear

P<0.001). Further, among lung cancer patients, hospital costs

to be consistent with previous reports of depression prevalence

were 31% higher among blacks than among whites ($94,888

(11%–44%) among lung cancer patients [72]. In our study,

vs. $69,575, P<0.001, Table 4), and 5% higher among men

whites and female patients, as in a previous study [13], had a

than among women ($74,286 vs. 70,829, P<0.04). The higher

more frequent occurrence of depression than their black and

costs among lung cancer patients (total group) compared with

male counterparts. In blacks and men, the depression diagno-

patients without lung cancer were due in part to the greater

sis may be made less frequently, in part, because physicians

number of comorbidities that lung cancer patients had (2.31 vs.

may not ask about their symptoms and these groups of patients

1.56, P<0.001), more admissions (2.24 vs. 1.53, P<0.001), and

do not readily admit to being depressed [73–76].

longer hospital stays (14 days vs. 8 days).

those with a prior diagnosis of lung cancer. All diagnoses were

Racial differences were very pronounced with regard to
the prevalence of lung cancer. Here, the rates were higher for

Smoking and depression costs: Hospital costs differed

blacks than for whites, higher among men than among women;

significantly by the subgroup of lung cancer patients (Table 4).

both black men and black women had higher lung cancer rates

For instance, the costs were 35% higher for smokers than for

than white men and white women. These findings in Tennessee
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0.58–0.81 0.58–0.81

0.69

1.40*

0.89

OR

AF

0.93

0.76–0.88 0.82–1.08

0.77

Stroke

1.12 (NS)

1.00–1.30 0.96–1.30

1.18*

0.84–0.95

CI

MI

0.76

0.74–0.86 0.67–0.85

0.80

0.82

OR

CKD

CI

OR

0. 90

0.98–1.12 0.87–1.11

1.05

0.90

1.06–1.24

CI

CHD

1.15*

OR

High cholesterol level

0.81

OR

DM

1.05

OR

HTN

patients

factors

history

All lung cancer Smoking Depression

Risk

1.01

White

0.91

Male

1.24*

Female

WM

1.01 (NS) 0.90

BM

2.00*

BF

1.16*

WF

0.89

DM

0.81

0.84

0.76

0.81

0.84

0.80

0.75

–

1.38*

1.15†
1.30*

1.13

0.88

1.19*

1.10 (NS)

0.91

0.83

0.85

0.72

0.85

0.83

0.87

0.91

0.76

0.66

0.76

0.41

0.72

0.65

0.78

0.72

0.64

0.63

0.76

0.83

0.61

1.01

0.72

0.58

0.87

0.81

0.99

0.81

0.81

1.17 (NS) 0.96

0.70

1.39*

1.36*

1.36*

1.43*

1.35*

1.36*

1.36*

1.32*

5.11*

5.34*

4.82*

7.36*

5.09*

4.59*

4.86*

3.63*

2.92*

2.15*

3.80*

2.50*

2.11*

4.30*

3.67*

3.09*

2.53*

3.33–4.06

3.68*

1.11–1.32

1.21*

0.76–0.97

0.86

0.60–0.77

0.68

0.65–0.82

0.73

–

–

0.95–1.19

1.06

0.72–0.86

0.78

0.76–0.96

0.85

CHD

0.86

0.81

0.92

0.86

0.91

0.94

0.92

0.84

0.70–1.05 0.77–0.88 0.74–0.88 0.85–1.01 0.65–1.17 0.74–0.89 0.72–1.23 0.85–1.01 0.75–0.94

0.81

0.82–0.90

0.93

3.20–4.32 2.76–3.10 2.00–2.31 3.49–4.12 2.04–3.06 1.95–2.28 3.43–5.38 3.35–4.02 22.76–3.45 2.31–2.79

3.72*

5.32–7.17 4.82–5.43 4.97–5.74 4.42–5.25 6.05–8.91 4.71–5.50 3.65–5.75 4.42–5.33 3.24–4.06

6.18*

1.23–1.72 1.31–1.48 1.27–1.47 1.24–1.49 1.15–1.78 1.25–1.47 1.04–1.76 1.24–1.50 1.18–1.47

1.45*

0.79–1.23 0.80–0.96 0.73–0.91 0.87–1.12 0.59–1.10 0.72–0.92 0.85–1.60 0.83–1.10 0.65–0.84

0.98

0.63–1.30 0.56–0.74 0.53–0.73 0.62–0.94 0.50–1.37 0.51–0.72 0.60–1.72 0.57–0.91 0.46–0.73

0.90

0.41–0.64 0.69–0.83 0.59–0.74 0.65–0.87 0.31–0.55 0.64–0.81 0.47–0.89 0.66–0.91 0.63–0.82

0.51

0.95–0.93 0.86–0.97 0.77–0.90 0.78–0.92 0.56–0.91 0.78–0.92 0.63–1.10 0.78–0.96 0.82–0.99

0.78

0.83–1.30 1.06–1.26 1.02–1.27 1.01–1.30 0.91–1.84 1.01–1.28 0.56–1.29 1.04–1.36 0.96–1.27

1.08 (NS) 1.16*

0.68–0.94 0.76–0.86 0.77–0.90 0.69–0.83 0.66–1.01 0.77–0.91 0.63–1.01 0.67–0.83 –

0.80

1.16–1.62 0.95–1.08 0.84–0.98 1.13–1.35 0.81–1.25 0.83–0.97 1.53–2.62 1.06–1.27 0.76–0.92

1.37*

Black

Table 2. Odds ratios and 95% of confidence intervals of cardiovascular disease risk factors predicting lung cancer among subgroups of lung cancer patients
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2.37–3.47

CI

Significant P<0.04.

2.03*

2.17–3.39 1.41–2.92

2.71*

2.99*

White

2.98*

Male

2.58*

Female

3.02*

BM

2.07*

WM

WF

1.21 (NS) 2.85*

BF

2.27*

DM

1.19–3.70 2.44–3.66 2.33–3.82 1.92–3.47 2.50–6.09 2.28–3.88 1.35–3.56 1.98–3.88 1.58–3.40

2.10*

Black

1.98–3.91

2.77*

CHD

7.59

41,264

Hospital days

Total cost ($)

71,850*

13.90*

2.24*

2.31*

patients (n=6665)

Total lung cancer

Lung cancer patients

56,931

11.76

1.74

2.44

No (n=2246)

Smoker

80,848*

15.32*

2.43*

3.85

Yes (n=4419)

65,075

12.34

1.95

3.01

No (n=5068)

Depressed

97,265*

19.77*

2.99*

4.54

Yes (n=1597)

The percentage value between two values (e.g., $71,850 and $41,264=54%) was calculated by [(V1–V2)/(V1+V2/2)]×100.

*Differences between two adjacent columns are significant at P<0.001.

1.56

1.53

Comorbidities

Admissions

(n=393,570)

cancer

No lung

Table 3. Cost factors and effect of smoking and depression on hospital cost of lung cancer

52,216

10.49

1.62

2.15

No (n=1824)

104,434*

20.66*

3.26*

4.84

Yes (n=1175)

Smoker and depressed

pulmonary disease; DM, diabetes mellitus; HTN, hypertension; MI, myocardial infarction; OR, odds ratio; NS, not significant; WF, white female; WM, white male.

AF, atrial fibrillation; BF, black female; BM, black male; CHD, coronary heart disease; CI confidence interval; CKD, chronic kidney disease; COPD, chronic obstructive

†

*Significant at P<0.001.

2.87*

OR

Obesity

patients

factors

history

All lung cancer Smoking Depression

Risk

Table 2 (conitnued)
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Table 4. Cost factors and total cost of lung cancer alone and with smoking and depression by race and sex
Cost factors

Black
LC

White
LC+S+D

LC

Yes

No

Male
LC+S+D

LC

Yes

No

Female
LC+S+D

LC

Yes

No

LC+S+D
Yes

No

N

881

83

250

5,784

1092

1574

3,780

517

1045

2,885

659

6,665

Comorbidities

3.21

4.75*

2.28

3.40

4.85

2.13

3.45

5.02*

2.27

3.28

4.70*

1.97

Admissions

2.34+

4.04*

1.70

2.18

3.20

1.61

2.19

3.40*

1.98

2.21

3.09*

1.69

Hospital days

18.20

27.45*

13.9

13.50

20.15

9.96

14.00

21.50*

10.45

14.27

20.00*

10.53

Total cost ($)

94,888

141,480*

69,450

69,575

101,620*

48,479

74,286

113,480*

53,166

70,829

97,324*

50,941

*Differences between two adjacent are significant at P<0.0001.
LC, lung cancer patients; LC+S+D, lung cancer patients who are both smokers and depressed.

Table 5. Effect of smoking plus depression by race and sex
Black male

White male

Black female

White female

LC

LC

LC

LC

LC+S+D
Yes

No

LC+S+D
Yes

No

LC+S+D
Yes

No

47

124

LC+S+D
Yes

No

2,498

611

655

N

494

36

250

3,286

481

919

387

Comorbidities

3.21

5.08*

2.29

3.49

5.02*

2.11

3.21

4.49*

2.26

3.29

4.72*

1.92

Admissions

2.26

4.39*

1.62

2.18

3.41*

1.57

2.45+

3.71*

1.79

2.17

3.03*

1.66

Hospital days

17.79

29.78*

13.13

13.47

20.88*

10.09

18.97*

25.66*

14.52

13.74

19.57*

9.79

Total cost ($)

91,384

159,950*

64,059

71,716

110,380*

51,673

97,085*

131,160*

74,928

66,758

94,721*

46,400

*Differences between two adjacent columns are significant at P<0.001.
LC, lung cancer patients; LC+S+D, lung cancer patients who are both smokers and depressed.

(a tobacco-producing state) are very similar to those for lung

factors emerged when separate analyses were conducted for

cancer in Kentucky (also a tobacco-producing state), and they

subgroups such as depressed patients or those with a smoking

provide supportive evidence for reported race and sex differ-

history or those with diabetes mellitus or CHD (Table 2).

ences in lung cancer [3, 7].

The anticipated relationships (e.g., lung cancer and myocar-

Our analyses also delineated a set of four risk factors that

dial infarction or stroke as reported earlier) [31, 49, 50] were

were consistently related to lung cancer across all subgroups

nonexistent in these analyses. This may have been due to either

of patients: smoking, atrial fibrillation, COPD, and obesity.

patients being in treatment or the low prevalence of these risk

These findings substantiated what has been reported previ-

factors in the present sample. The latter is particularly true for

ously for lung cancer [53, 54, 57, 67], and they further provide

myocardial infarction and stroke, which existed only among less

supportive evidence for the inflammation hypothesis linking

than 10% of our lung cancer patients. Thus CHD did not show a

CVD and cancers [60]. However, our multivariate analyses

relationship with lung cancer in our analyses (Table 2). However,

did not find any additional risk factor in relation to lung cancer

a relationship between CHD and atrial fibrillation could develop

except for hypertension among black patients (OR 1.37, 95%

(within 14 months after treatment) because of cancer treatment

CI 1.16–1.62), and high cholesterol level among white patients

modalities such as radiation therapy, chemotherapy, and surgery

(OR 1.16, 95% CI 0.06–1.26). Little variation in additional risk

[54, 76]. The occurrence of atrial fibrillation may be higher

37 
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among cancer patients because of frequent use of aspirin, which

contributed to reductions in cancer mortality [87], there is

reportedly increases atrial fibrillation by 12% [77]. Hence the

a great need to continue implementing culturally appropri-

presence of atrial fibrillation (which existed in 34% of our CHD

ate, evidence-based tobacco cessation programs in the most

patients) may occur from nonsteroidal anti-inflammatory drug

vulnerable groups; blacks are prominent among such groups.

use. However, it is not clear from our limited data whether these

Programs might include American Cancer Society guidelines

CVD risk factors existed before the onset of lung cancer or

[83] to reinforce other healthy choices (nutritional and exer-

developed after the diagnosis of lung cancer. Despite this limi-

cise) as well as individualized counseling by service provid-

tation, our results point to a clear link between the effect of lung

ers that includes both patient empowerment and greater use

cancer and both smoking and depression independently as well

of the Quit Line services. Lowering smoking rates through

as their joint effect (74% of depressed patients had smoked) on

such proven programs would not only be beneficial in reduc-

increased hospitalization costs (which increased by more than

ing healthcare costs (estimated at $12.1 billion for lung can-

50%), with some race and sex variation. Since 66% of all lung

cer [88]), but may also reduce cancer morbidity and mortality

cancer patients smoked (past or present), an additional observa-

[82, 87].

tion about its effect needs to be acknowledged—namely, that it

Secondly, our analyses showed that 74% of the depressed

is the number of years of smoking (rather than the quantity of

patients were smokers. Generally, depression, which has a

cigarettes smoked alone) that may also play a critical role in the

prevalence of 11%–44% among cancer patients [72], is bidi-

development of lung cancer [78].

rectional in that it may occur before the onset of a disease

Finally, the average hospital cost for lung cancer patients

(lung cancer in this case), or it may develop as a psychoso-

was 54% higher than that for patients without lung cancer. This

cial response to the diagnosis of lung cancer. In either case,

cost among lung cancer patients increased additionally by 35%

depression should be treated aggressively since it interferes

for smokers and 40% for depressed patients (Table 3). These

with both self-management and treatment of a medical condi-

costs more than doubled (>50%) for patients who were both

tion. Additionally, focus must be given to treatment modalities

smokers and depressed (Tables 3 and 4). Further, these higher

that avoid reoccurrence of depressive episodes. Further, since

cost trends held up for race and sex, whereby black and male

one-fourth of these patients were depressed and their hospi-

patients had higher costs than their white and female peers.

tal costs were noticeably higher, significant economic savings

The higher costs among black lung cancer patients suggest that

might be attainable if these patients were screened and treated

black patients may have poor access to healthcare providers

for depression in conjunction with cancer treatment.

(because of rates of lower insurance, poor symptom recogni-

Finally, if evidence-based smoking cessation programs

tion, and/or late referrals [79–82]), may be reluctant to seek

that incorporate the American Cancer Society guidelines [89]

medical care during the early stages of disease especially if

to reinforce a healthy lifestyle (nutritional diet and exercise)

they are depressed [83], may experience more aggressive dis-

are implemented in the minority population, such programs

ease [84], or may access the healthcare system late in the pro-

would not only reduce hospitalization costs but would also

gression of their disease. In any case, this late involvement may

reduce cancer morbidity significantly [90].

lead to more complex medical conditions that require a longer
hospital stay and thus higher costs for blacks. Moreover, these

Limitations

higher hospital costs for male and black patients appear to be

Our findings are limited since hospital discharge files (HDDS)

consistent with the higher hospital costs reported for blacks

do not include veterans or patients from mental institutions.

with CVD events such as stroke and heart failure [62, 85, 86].

Further, the HDDS data are administrative files that neither
provide data pertaining to patients’ marital status, education,

Implications

and annual income nor clinical data regarding medications

Our findings relative to smoking and depression have pro-

used, test results, the severity of illness, or symptom indi-

grammatic implications. First, since smoking reduction has

ces used for clinical judgments/diagnoses. These files do not
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provide information on reimbursed dollars for the services pro-

Human Services, Centers for Disease Control and Prevention,

vided. For the sake of maintaining confidentiality of records,

National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health; 2014.

patients’ assigned identification numbers change every year,
and hence it is not possible to follow a patient beyond a given

2.

cular events and mortality among older adults: meta-analysis of

year. Given these potential confounders, caution is required

individual participant data from prospective cohort studies of the

in interpreting the racial and sex results. Despite these limitations, we believe the present results provide significant
insights into the impact of smoking and depression on hospitalization costs of lung cancer in Tennessee that may have
national utility.

Mons U. Impact of smoking and smoking cessation on cardiovas-

CHANCES consortium. Br Med J 2015;350(apr20 2):h1551.
3.

Slegel RL, Miller KD, Jemal A. Cancer statistics. 2016. CA Cancer J Clin 2016;66(1):7–30.

4.

Eldridge L. [Internet] Important facts about lung cancer. [accessed
2016 Nov 17]. Available from: https://www.verywell.com/
facts-about-lung-cancer-2249396?utm_term=lung+cancer+

Conclusion

facts&utm_content=p1-main-1-title&utm_medium=sem&utm_

Lung cancer rates and hospital costs are higher for blacks and

s o u r c e = m s n _ s & u t m _ c a m p a i g n = a d i d - 8 d 3 c 0 7 b 3 - ff 2 7 -

those who smoke and are depressed. Since depression exists

4a1b-99a5-a5138ab860ef-0-ab_msb_ocode 31716&ad=semD&

among one-quarter of lung cancer patients, greater cost sav-

an=msn_s&am=broad&q=lung+cancer+facts&o=31716&qsrc=

ings might be attained if depression is treated among lung

999&l=sem&askid=8d3c07b3-ff27-4a1b-99a5-a5138ab860ef-

cancer patients as soon as it is diagnosed. Finally, culturally

0-ab_msb.

appropriate, evidence-based smoking cessation programs

5.

cancer, 2006. Statistical brief #63, Healthcare Cost & Utilization

might go a long way toward reducing cancer morbidity in the

Project (HCUP), Agency for Healthcare Research & Quality;

minority populations.
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